7FR-30397-67473
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 460 / IN
- Registered
- 2021-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Dose 1 — Janssen/Johnson & Johnson
-
2021-12-12
Dose 2 — Pfizer-BioNTech
-
2021-12-20
Registered in v-safe
-
2021-12-20
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend schoolAdult check-in
-
2021-12-26
Survey response — day 14, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Head achesMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Janssen/Johnson & Johnson | No |
| 2 | 2021-12-12 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 2
Symptoms: Head aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release